US$ 28.37
glp 1 agonist muscle loss Weighing the risk of GLP-1 treatment in older adults: Should we be concerned about sarcopenic obesity? What Are GLP-1 Agonists For
Description
doi: 10.1016/S0140-6736(16)31679-8 Erratum in: Lancet

For more information, visit www.nclnet.org.
Knockdown of GLP-1 receptors in vagal afferents affects normal food intake and glycemia

132 Glutamate receptors, including the amino-3-hydroxy-5-methyl-4-isoxazolepro-pionicacid (AMPA) and N-methyl-D-aspartate (NMDA) receptors, mediate excitatory synaptic transmission in the CNS, and its expression in the postsynaptic membrane is associated with LTP and LTD and is involved in the regulation of learning and memory activities

increasing heart rate, reducing LVEF [43-45]
